Clinical trial
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or…
NCT00070304 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00070304 |
|---|---|
| Title | Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma |
| Official title | A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, gemcitabine hydrochloride, vinorelbine tartrate |
| Enrollment | 33 |
| Start date | Jul 1, 2004 |
| Primary completion | Sep 1, 2007 |
| First posted | Oct 7, 2003 |
| Last update posted | Jul 26, 2013 |
| Countries | Australia, Canada, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: